Company to buy
- Size: medium-sized business
- Revenue: 3-50 M EUR
- Location of the target company: Europe.
- Reason for acquisition: The company wants to enhance its portfolio and expand on several markets wordwide.
- #CFIE PHB032
Overview of the pharmaceutical manufacturing unit wanted
This buyer is looking for a new acquisition worldwide. The company is interested to acquire pharmaceutical distribution firm that has products for treatment of acute and chronic conditions in form of tablets and capsules such as oral solid dose, liquids, semi-solids and others. The company should preferably generates sustainable revenue and should have a potential growth.
Profile (strategy) of pharmaceutical manufacturing buyer
A large company with more than 2500 employees in more than 100 countries, focusing on branded and generic pharmaceuticals with basket of products that provide treatment for acute and chronic conditions. Are in which the company operates: thrombosis, anesthetics, high potency & cytotoxic and nutritionals. The company holds international manufacturing approvals from regulatory agencies such as the United States Food and Drug Administration, the Australian Therapeutic Goods Administration and the European Directorate for the Quality of Medicines. Manufacturing products include: oral solid dose, liquids, semi-solids, sterile, biologicals, active pharmaceutical ingredients and nutritionals.
Contact us to get details about this pharma manufacturing site.
Activities and products of the target pharmaceutical manufacturing unit
The buyer is now looking for a company with products that provide treatment for a broad spectrum of acute and chronic conditions experienced through all stages of life. Preferred company has experiences with manufacturing products such as oral solid dose, liquids, semi-solids, sterile, biologicals, active pharmaceutical ingredients and nutritionals.
Operates in thrombosis, anesthetics, high potency & cytotoxic or nutritionals areas.
The goal of the buyer is to acquire profitable manufacturing pharma company with EBITDA in the range of 3-50 million euros.
Highlights of the pharmaceutical manufacturing buyer
- A large generic and branded pharmaceutical company with intensive M&A activities.
- The buyer is interested in branded and generic pharmaceutical companies that have products for treatment of acute and chronic conditions.
- Desired company operates in thrombosis, anaesthetics, high potency & cytotoxics or nutritionals areas.
- Has experiences with manufacturing products such as oral solid dose, liquids, semi-solids, steriles, biologicals, active pharmaceutical ingredients and nutritionals.
More information on this buyer for pharma manufacturing site in Europe
Please get in touch if you are interested in learning more about this buyer for pharma manufacturing site in Europe. For more pharma companies for sale please visit the section pharma companies for sale. For other pharma buyers, please visit the section pharma companies wanted. If you are instead interested in pharma companies for sale, please visit the pharma companies for sale section. For pharma buyers, please visit the section pharma companies wanted.